Retatrutide peptides are unapproved. Clinician-led GLP-1 care is the alternative.
Retatrutide is investigational — still in clinical trials, not FDA-approved, and the peptides sold online are unregulated research chemicals with no oversight. Healthspan offers the opposite: FDA-approved GLP-1 medication, evaluated and dosed by a licensed clinician and monitored with real labs.
What real GLP-1 care includes — the oversight a research peptide leaves out entirely.
0
Unapproved compounds
Healthspan prescribes GLP-1 medications the FDA has already reviewed and approved — never an investigational peptide sold "for research only."
70
+
Biomarkers tracked
Baseline and follow-up labs across nine biological systems, so dosing is grounded in your bloodwork — not a vial and a guess.
100
%
Clinician-evaluated
A licensed clinician reviews your history and goals and determines whether a GLP-1 is appropriate — based on more than BMI alone.
1
Licensed pharmacy
Your medication is dispensed by a licensed U.S. pharmacy and shipped to you — not bought as an unregulated peptide online.
Clinician-led GLP-1 care vs retatrutide peptides online
The differences that decide whether you're getting a monitored medicine or an unregulated chemical.
Healthspan
FDA-approved medication
A GLP-1 the FDA has reviewed and approved — such as semaglutide or tirzepatide — prescribed for you, not an investigational compound.
Clinician evaluation first
A licensed clinician reviews your history, goals, and labs and confirms whether a GLP-1 is appropriate — not BMI alone.
Human-grade, licensed pharmacy
Dispensed by a licensed U.S. pharmacy as a quality-controlled medication intended for human use.
Dosed and monitored
Clinician-guided titration and up to three comprehensive lab panels a year across 70+ biomarkers.
Someone accountable
A clinician and a 1:1 expert stay involved — adjusting the protocol and managing side effects over time.
Retatrutide peptides online
Investigational, unapproved
Retatrutide is still in clinical trials and isn’t FDA-approved, so it can’t be legally prescribed or sold as a medicine.
No evaluation
A checkout page doesn’t review your history, medications, or labs, or decide whether it’s appropriate for you.
Unregulated "research" chemical
Often labeled "not for human consumption," with purity, potency, and sterility unverified for medical use.
No dosing or monitoring
You reconstitute and dose a vial yourself, with no titration plan and no labs tracking how you respond.
No one accountable
No clinician, no pharmacy oversight, and no one to catch a problem or manage a side effect.
What's included
Care around the medication, not a vial and a guess
How we keep GLP-1 care safe
Healthspan prescribes GLP-1 medications that have been through FDA review — never an investigational compound like retatrutide that hasn’t been approved for any use.
A licensed clinician reviews your medical history, current medications, and goals to decide whether a GLP-1 is appropriate for you at all — and screens for the situations where it isn’t.
Baseline labs establish your starting point; follow-up labs across 70+ biomarkers track how your body responds, so changes are caught early rather than assumed away.
Medication is dispensed through a licensed pharmacy and shipped to you, and your clinician stays involved — adjusting or pausing the protocol based on your labs and symptoms.
Shopping the peptide
The retatrutide peptide alternative, explained
Common questions about retatrutide peptides
No. Retatrutide is an investigational medicine — a triple hormone receptor agonist (GLP-1, GIP, and glucagon) that is still in clinical trials and has not been approved by the FDA for any use. Because it isn’t approved, it can’t be legally prescribed or sold as a medication in the US. If you want GLP-1-based metabolic care now, the clinician-led path uses GLP-1 medications that the FDA has already reviewed and approved.
The "retatrutide peptides" sold online are unregulated research chemicals, often labeled "for research use only" or "not for human consumption." They aren’t made or reviewed as medicines: purity and potency aren’t verified, there’s no dosing guidance, and no clinician screens you for the interactions and conditions that make a given treatment unsafe for you. Buying and self-administering an unapproved compound this way carries real risk, which is exactly what a licensed, monitored program is designed to remove.
The alternative is a GLP-1 medication that has actually been through FDA review — for example semaglutide (Wegovy) or tirzepatide (Zepbound) — prescribed and managed by a licensed clinician. Healthspan’s GLP-1 program evaluates whether a GLP-1 is appropriate based on your history and goals, includes baseline and follow-up labs, and dispenses medication through a licensed pharmacy. You get GLP-1-based care with real oversight instead of an unapproved vial from the internet.
Every part that a research peptide skips is built in. A licensed clinician confirms a GLP-1 is medically appropriate for you, medication is dispensed by a licensed pharmacy as a human-grade product, dosing is titrated and adjusted over time, and up to three comprehensive lab panels a year track 70+ biomarkers across nine biological systems. A gray-market peptide gives you a compound and nothing else; a program gives you the care around it.
Healthspan’s GLP-1 Longevity Care membership starts at $99/mo and covers the clinical evaluation, ongoing biomarker tracking (up to three comprehensive lab panels a year), dose optimization and monitoring, and a 1:1 longevity expert. Medication is billed separately based on the prescription and pharmacy. You can cancel anytime, and the membership is HSA/FSA eligible.
GLP-1 medications are FDA-approved for chronic weight management and type 2 diabetes in eligible patients. Using them for general "longevity," "anti-aging," or wellness is off-label. Healthspan makes no anti-aging or guaranteed weight-loss promises — a licensed clinician determines whether a GLP-1 is medically appropriate for you based on your history, goals, and labs, and not everyone qualifies.
No. Retatrutide is an investigational medicine — a triple hormone receptor agonist (GLP-1, GIP, and glucagon) that is still in clinical trials and has not been approved by the FDA for any use. Because it isn’t approved, it can’t be legally prescribed or sold as a medication in the US. If you want GLP-1-based metabolic care now, the clinician-led path uses GLP-1 medications that the FDA has already reviewed and approved.
The "retatrutide peptides" sold online are unregulated research chemicals, often labeled "for research use only" or "not for human consumption." They aren’t made or reviewed as medicines: purity and potency aren’t verified, there’s no dosing guidance, and no clinician screens you for the interactions and conditions that make a given treatment unsafe for you. Buying and self-administering an unapproved compound this way carries real risk, which is exactly what a licensed, monitored program is designed to remove.
The alternative is a GLP-1 medication that has actually been through FDA review — for example semaglutide (Wegovy) or tirzepatide (Zepbound) — prescribed and managed by a licensed clinician. Healthspan’s GLP-1 program evaluates whether a GLP-1 is appropriate based on your history and goals, includes baseline and follow-up labs, and dispenses medication through a licensed pharmacy. You get GLP-1-based care with real oversight instead of an unapproved vial from the internet.
Every part that a research peptide skips is built in. A licensed clinician confirms a GLP-1 is medically appropriate for you, medication is dispensed by a licensed pharmacy as a human-grade product, dosing is titrated and adjusted over time, and up to three comprehensive lab panels a year track 70+ biomarkers across nine biological systems. A gray-market peptide gives you a compound and nothing else; a program gives you the care around it.
Healthspan’s GLP-1 Longevity Care membership starts at $99/mo and covers the clinical evaluation, ongoing biomarker tracking (up to three comprehensive lab panels a year), dose optimization and monitoring, and a 1:1 longevity expert. Medication is billed separately based on the prescription and pharmacy. You can cancel anytime, and the membership is HSA/FSA eligible.
GLP-1 medications are FDA-approved for chronic weight management and type 2 diabetes in eligible patients. Using them for general "longevity," "anti-aging," or wellness is off-label. Healthspan makes no anti-aging or guaranteed weight-loss promises — a licensed clinician determines whether a GLP-1 is medically appropriate for you based on your history, goals, and labs, and not everyone qualifies.
See if GLP-1
- is right
- fits you
- is for you
for your goals
Start with an evaluation
()
Take the 2-minute assessment. A licensed clinician reviews your eligibility and, if an FDA-approved GLP-1 is appropriate, builds a monitored protocol around your labs and goals.
From $99/mo · HSA/FSA eligible · Cancel anytime
Retatrutide is an investigational medicine that is still in clinical trials and is not approved by the FDA for any use; it cannot be legally prescribed or sold as a medication, and peptides marketed online are unregulated. Healthspan does not sell retatrutide. The GLP-1 medications Healthspan offers are prescription treatments FDA-approved for chronic weight management and type 2 diabetes in eligible patients; use for general wellness, "longevity," or "anti-aging" is off-label. A licensed clinician determines whether a GLP-1 is medically appropriate for you based on your history, goals, and labs; not everyone qualifies. Membership starts at $99/mo and medication is billed separately. This page is educational and not medical advice, and individual results vary. Medically reviewed by the Healthspan Clinical Team on 2026-07-29.